Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022

SELL
$140.68 - $188.02 $844 - $1,128
-6 Reduced 18.18%
27 $4,000
Q1 2022

May 11, 2022

BUY
$161.19 - $257.96 $1,289 - $2,063
8 Added 32.0%
33 $6,000
Q4 2021

Jan 10, 2022

BUY
$247.59 - $304.47 $4,704 - $5,784
19 Added 316.67%
25 $7,000
Q2 2021

Jul 30, 2021

BUY
$165.87 - $220.95 $331 - $441
2 Added 50.0%
6 $1,000
Q1 2021

Apr 29, 2021

SELL
$180.37 - $226.26 $360 - $452
-2 Reduced 33.33%
4 $1,000
Q4 2020

Jan 15, 2021

BUY
$148.08 - $206.57 $296 - $413
2 Added 50.0%
6 $1,000
Q2 2020

Jul 10, 2020

SELL
$94.33 - $140.48 $377 - $561
-4 Reduced 50.0%
4 $0
Q1 2020

Apr 15, 2020

BUY
$84.96 - $109.14 $679 - $873
8 New
8 $1,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.77B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Patriot Financial Group Insurance Agency, LLC Portfolio

Follow Patriot Financial Group Insurance Agency, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.